Adaptation to survival in germinal center is the initial step in onset of indolent stage of multiple myeloma

Molecular Pharmaceutics

Volumn 8, Issue 6, 2011, Pages 2012-2020

  Silva, Ariosto S ^a   Gatenby, Robert A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

germinal center; lymphoma; multiple myeloma; somatic evolution; tumor microenvironment

Indexed keywords

ADAPTATION; ANGIOGENESIS; ARTICLE; CELL DIVISION; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; GERMINAL CENTER; HYPOXIA; MOLECULAR EVOLUTION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PHENOTYPE; PRIORITY JOURNAL; SIMULATION;

CELL PROLIFERATION; CELL SURVIVAL; COMPUTER SIMULATION; GERMINAL CENTER; HUMANS; MULTIPLE MYELOMA;

EID: 82955169638     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200279p     Document Type: Article

References (43)

1. Klein, B.; Zhang, X. G.; Lu, Z. Y.; Bataille, R. Interleukin-6 in human multiple myeloma Blood 1995, 85 (4) 863-72
2. Heinrich, P. C.; Castell, J. V.; Andus, T. Interleukin-6 and the acute phase response Biochem. J. 1990, 265 (3) 621-36 (Pubitemid 20053863)
3. Hirano, T.; Yasukawa, K.; Harada, H.; Taga, T.; Watanabe, Y.; Matsuda, T.; Kashiwamura, S.; Nakajima, K.; Koyama, K.; Iwamatsu, A. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin Nature 1986, 324 (6092) 73-6 (Pubitemid 16008419)
4. Symeonidis, A.; Kouraklis-Symeonidis, A.; Grouzi, E.; Zolota, V.; Melachrinou, M.; Kourea, K.; Fragopanagou, E.; Giannakoulas, N.; Seimeni, U.; Tiniakou, M.; Matsouka, P.; Zoumbos, N. Determination of plasma cell secreting potential as an index of maturity of myelomatous cells and a strong prognostic factor Leuk. Lymphoma 2002, 43 (8) 1605-12 (Pubitemid 34823481)
5. Hallek, M.; Bergsagel, P. L.; Anderson, K. C. Multiple myeloma: increasing evidence for a multistep transformation process Blood 1998, 91 (1) 3-21 (Pubitemid 28018724)
6. Kuehl, W. M.; Bergsagel, P. L. Multiple myeloma: evolving genetic events and host interactions Nat. Rev. Cancer 2002, 2 (3) 175-87 (Pubitemid 37328787)
7. Klein, U.; Dalla-Favera, R. Germinal centres: role in B-cell physiology and malignancy Nat. Rev. Immunol. 2008, 8 (1) 22-33
8. Guzman-Rojas, L.; Sims-Mourtada, J. C.; Rangel, R.; Martinez-Valdez, H. Life and death within germinal centres: a double-edged sword Immunology 2002, 107 (2) 167-75 (Pubitemid 35279042)
9. Alabyev, B.; Vuyyuru, R.; Manser, T. Influence of Fas on the regulation of the response of an anti-nuclear antigen B cell clonotype to foreign antigen Int. Immunol. 2008, 20 (10) 1279-87
10. Korsmeyer, S. J. Bcl-2 initiates a new category of oncogenes: regulators of cell death Blood 1992, 80 (4) 879-86
11. van Eijk, M.; Medema, J. P.; de Groot, C. Cutting edge: cellular Fas-associated death domain-like IL-1-converting enzyme-inhibitory protein protects germinal center B cells from apoptosis during germinal center reactions J. Immunol. 2001, 166 (11) 6473-6 (Pubitemid 32467183)
12. Toellner, K. M.; Scheel-Toellner, D.; Sprenger, R.; Duchrow, M.; Trumper, L. H.; Ernst, M.; Flad, H. D.; Gerdes, J. The human germinal centre cells, follicular dendritic cells and germinal centre T cells produce B cell-stimulating cytokines Cytokine 1995, 7 (4) 344-54
13. Wu, Y.; El Shikh, M. E.; El Sayed, R. M.; Best, A. M.; Szakal, A. K.; Tew, J. G. IL-6 produced by immune complex-activated follicular dendritic cells promotes germinal center reactions, IgG responses and somatic hypermutation Int. Immunol. 2009, 21 (6) 745-56
14. Fonseca, R.; Barlogie, B.; Bataille, R.; Bastard, C.; Bergsagel, P. L.; Chesi, M.; Davies, F. E.; Drach, J.; Greipp, P. R.; Kirsch, I. R.; Kuehl, W. M.; Hernandez, J. M.; Minvielle, S.; Pilarski, L. M.; Shaughnessy, J. D., Jr.; Stewart, A. K.; Avet-Loiseau, H. Genetics and cytogenetics of multiple myeloma: a workshop report Cancer Res. 2004, 64 (4) 1546-58 (Pubitemid 38235629)
15. Kuehl, W. M.; Bergsagel, P. L. Early genetic events provide the basis for a clinical classification of multiple myeloma Hematology 2005, 346-52
16. Bergsagel, P. L.; Kuehl, W. M. Molecular pathogenesis and a consequent classification of multiple myeloma J. Clin. Oncol. 2005, 23 (26) 6333-8 (Pubitemid 46218843)
17. Bergsagel, P. L.; Kuehl, W. M.; Zhan, F.; Sawyer, J.; Barlogie, B.; Shaughnessy, J., Jr. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma Blood 2005, 106 (1) 296-303 (Pubitemid 40967205)
18. Gatenby, R. A.; Gillies, R. J.; Brown, J. S. The evolutionary dynamics of cancer prevention Nat. Rev. Cancer 2010, 10 (8) 526-7
19. Martinez-Valdez, H.; Guret, C.; de Bouteiller, O.; Fugier, I.; Banchereau, J.; Liu, Y. J. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2 J. Exp. Med. 1996, 183 (3) 971-7
20. Podar, K.; Tai, Y. T.; Davies, F. E.; Lentzsch, S.; Sattler, M.; Hideshima, T.; Lin, B. K.; Gupta, D.; Shima, Y.; Chauhan, D.; Mitsiades, C.; Raje, N.; Richardson, P.; Anderson, K. C. Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration Blood 2001, 98 (2) 428-35
21. Colla, S.; Storti, P.; Donofrio, G.; Todoerti, K.; Bolzoni, M.; Lazzaretti, M.; Abeltino, M.; Ippolito, L.; Neri, A.; Ribatti, D.; Rizzoli, V.; Martella, E.; Giuliani, N. Low bone marrow oxygen tension and hypoxia-inducible factor-1alpha overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells Leukemia 2010, 24 (11) 1967-70
22. Alarcon, T.; Byrne, H. M.; Maini, P. K. A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells J. Theor. Biol. 2004, 229 (3) 395-411 (Pubitemid 38844943)
23. Meads, M. B.; Hazlehurst, L. A.; Dalton, W. S. The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance Clin. Cancer Res. 2008, 14 (9) 2519-26
24. Ogata, A.; Chauhan, D.; Teoh, G.; Treon, S. P.; Urashima, M.; Schlossman, R. L.; Anderson, K. C. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade J. Immunol. 1997, 159 (5) 2212-21 (Pubitemid 127681011)
25. Sonneveld, P.; Schoester, M.; de Leeuw, K. In vitro Ig-synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors Br. J. Haematol. 1991, 79 (4) 589-94
26. Ribatti, D.; Vacca, A.; Nico, B.; Quondamatteo, F.; Ria, R.; Minischetti, M.; Marzullo, A.; Herken, R.; Roncali, L.; Dammacco, F. Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma Br. J. Cancer 1999, 79 (3-4) 451-5 (Pubitemid 29046218)
27. Asosingh, K.; De Raeve, H.; Menu, E.; Van Riet, I.; Van Marck, E.; Van Camp, B.; Vanderkerken, K. Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity Blood 2004, 103 (8) 3131-7 (Pubitemid 38451691)
28. De Raeve, H. R.; Asosingh, K.; Wisse, E.; Van Camp, B.; Van Marck, E.; Vanderkerken, K. Part of the multiple myeloma-associated microvessels is functionally connected to the systemic circulation: a study in the murine 5T33MM model Virchows Arch. 2004, 445 (4) 389-95 (Pubitemid 39517765)
29. Shweiki, D.; Itin, A.; Soffer, D.; Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 1992, 359 (6398) 843-5
30. Dong, Z.; Wang, J. Hypoxia selection of death-resistant cells. A role for Bcl-X(L) J. Biol. Chem. 2004, 279 (10) 9215-21 (Pubitemid 38295985)
31. Tafani, M.; Russo, A.; Di Vito, M.; Sale, P.; Pellegrini, L.; Schito, L.; Gentileschi, S.; Bracaglia, R.; Marandino, F.; Garaci, E.; Russo, M. A. Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment Cancer Sci 2010, 101 (4) 1014-23
32. Brooks, C.; Wang, J.; Yang, T.; Dong, Z. Characterization of cell clones isolated from hypoxia-selected renal proximal tubular cells Am. J. Physiol. 2007, 292 (1) F243-52
33. Liu, Y.; Song, X.; Wang, X.; Wei, L.; Liu, X.; Yuan, S.; Lv, L. Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells J. Cell. Biochem. 2010, 111 (3) 554-63
34. Giatromanolaki, A.; Bai, M.; Margaritis, D.; Bourantas, K. L.; Koukourakis, M. I.; Sivridis, E.; Gatter, K. C. Hypoxia and activated VEGF/receptor pathway in multiple myeloma Anticancer Res. 2010, 30 (7) 2831-6
35. Dankbar, B.; Padro, T.; Leo, R.; Feldmann, B.; Kropff, M.; Mesters, R. M.; Serve, H.; Berdel, W. E.; Kienast, J. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma Blood 2000, 95 (8) 2630-6 (Pubitemid 30210543)
36. Gupta, D.; Treon, S. P.; Shima, Y.; Hideshima, T.; Podar, K.; Tai, Y. T.; Lin, B.; Lentzsch, S.; Davies, F. E.; Chauhan, D.; Schlossman, R. L.; Richardson, P.; Ralph, P.; Wu, L.; Payvandi, F.; Muller, G.; Stirling, D. I.; Anderson, K. C. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications Leukemia 2001, 15 (12) 1950-61 (Pubitemid 33115003)
37. Tanaka, Y.; Abe, M.; Hiasa, M.; Oda, A.; Amou, H.; Nakano, A.; Takeuchi, K.; Kitazoe, K.; Kido, S.; Inoue, D.; Moriyama, K.; Hashimoto, T.; Ozaki, S.; Matsumoto, T. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin Clin. Cancer Res. 2007, 13 (3) 816-23 (Pubitemid 46340354)
38. Giuliani, N.; Colla, S.; Lazzaretti, M.; Sala, R.; Roti, G.; Mancini, C.; Bonomini, S.; Lunghi, P.; Hojden, M.; Genestreti, G.; Svaldi, M.; Coser, P.; Fattori, P. P.; Sammarelli, G.; Gazzola, G. C.; Bataille, R.; Almici, C.; Caramatti, C.; Mangoni, L.; Rizzoli, V. Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis Blood 2003, 102 (2) 638-45 (Pubitemid 36841986)
39. Vacca, A.; Ribatti, D. Bone marrow angiogenesis in multiple myeloma Leukemia 2006, 20 (2) 193-9 (Pubitemid 43148652)
40. Kumar, S.; Witzig, T. E.; Timm, M.; Haug, J.; Wellik, L.; Kimlinger, T. K.; Greipp, P. R.; Rajkumar, S. V. Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression Blood 2004, 104 (4) 1159-65 (Pubitemid 39038038)
41. Hose, D.; Moreaux, J.; Meissner, T.; Seckinger, A.; Goldschmidt, H.; Benner, A.; Mahtouk, K.; Hillengass, J.; Reme, T.; De Vos, J.; Hundemer, M.; Condomines, M.; Bertsch, U.; Rossi, J. F.; Jauch, A.; Klein, B.; Mohler, T. Induction of angiogenesis by normal and malignant plasma cells Blood 2009, 114 (1) 128-43
42. Hu, J.; Handisides, D. R.; Van Valckenborgh, E.; De Raeve, H.; Menu, E.; Vande Broek, I.; Liu, Q.; Sun, J. D.; Van Camp, B.; Hart, C. P.; Vanderkerken, K. Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug Blood 2010, 116 (9) 1524-7
43. Chapman, M. A.; Lawrence, M. S.; Keats, J. J.; Cibulskis, K.; Sougnez, C.; Schinzel, A. C.; Harview, C. L.; Brunet, J. P.; Ahmann, G. J.; Adli, M.; Anderson, K. C.; Ardlie, K. G.; Auclair, D.; Baker, A.; Bergsagel, P. L.; Bernstein, B. E.; Drier, Y.; Fonseca, R.; Gabriel, S. B.; Hofmeister, C. C.; Jagannath, S.; Jakubowiak, A. J.; Krishnan, A.; Levy, J.; Liefeld, T.; Lonial, S.; Mahan, S.; Mfuko, B.; Monti, S.; Perkins, L. M.; Onofrio, R.; Pugh, T. J.; Rajkumar, S. V.; Ramos, A. H.; Siegel, D. S.; Sivachenko, A.; Stewart, A. K.; Trudel, S.; Vij, R.; Voet, D.; Winckler, W.; Zimmerman, T.; Carpten, J.; Trent, J.; Hahn, W. C.; Garraway, L. A.; Meyerson, M.; Lander, E. S.; Getz, G.; Golub, T. R. Initial genome sequencing and analysis of multiple myeloma Nature 2011, 471 (7339) 467-72